We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Charles River Laboratories
CRL
$11.6B
| $3.01M | 0.01% |
15,313
-3,154
| -17% | -$681K |
|
652
UBS Group
UBS
$171B
| $3.01M | 0.01% |
189,694
-4,700
| -2% | -$75.2K |
|
653
BJs Wholesale Club
BJ
$12.4B
| $3.01M | 0.01% |
41,370
-13,475
| -25% | -$966K |
|
654
Bank of Montreal
BMO
$127B
| $3.01M | 0.01% |
31,429
+1,000
| +3% | +$96.7K |
|
655
Howmet Aerospace
HWM
$114B
| $2.99M | 0.01% |
96,777
+710
| +0.7% | +$24.9K |
|
656
Inspire Medical Systems
INSP
$1.5B
| $2.94M | 0.01% |
16,564
-132
| -0.8% | -$26.5K |
|
657
Pinnacle Financial Partners Inc
PNFP
$15.9B
| $2.94M | 0.01% |
36,191
| – | – |
|
658
Global Payments
GPN
$23.9B
| $2.93M | 0.01% |
27,082
-4,050
| -13% | -$500K |
|
659
EastGroup Properties
EGP
$11.3B
| $2.92M | 0.01% |
20,259
-3,090
| -13% | -$504K |
|
|
MPT
660
Medical Properties Trust
MPT
$2.89B
| $2.91M | 0.01% |
245,357
-26,750
| -10% | -$405K |
|
661
Manhattan Associates
MANH
$9.95B
| $2.91M | 0.01% |
21,845
| – | – |
|
662
Paylocity
PCTY
$7.43B
| $2.9M | 0.01% |
12,020
-1,960
| -14% | -$450K |
|
663
Toll Brothers
TOL
$14.5B
| $2.9M | 0.01% |
69,140
-5,730
| -8% | -$266K |
|
664
Henry Schein
HSIC
$9.76B
| $2.9M | 0.01% |
44,105
+7,825
| +22% | +$581K |
|
|
EXE
665
Expand Energy Corp
EXE
$21.2B
| $2.89M | 0.01% |
30,720
+10,490
| +52% | +$985K |
|
666
C.H. Robinson
CHRW
$20B
| $2.88M | 0.01% |
29,948
+6,290
| +27% | +$676K |
|
667
Viatris
VTRS
$20.8B
| $2.88M | 0.01% |
337,951
| – | – |
|
668
Boston Properties
BXP
$11.2B
| $2.85M | 0.01% |
38,008
+3,760
| +11% | +$320K |
|
|
ABMD
669
DELISTED
Abiomed Inc
ABMD
| $2.85M | 0.01% |
11,596
| – | – |
|
670
Equity Lifestyle Properties
ELS
$12.8B
| $2.83M | 0.01% |
45,110
+27,320
| +154% | +$1.96M |
|
671
Jefferies Financial Group
JEF
$13.2B
| $2.83M | 0.01% |
100,254
+2,129
| +2% | +$64.4K |
|
672
Texas Pacific Land
TPL
$26.9B
| $2.83M | 0.01% |
14,310
+2,160
| +18% | +$416K |
|
673
Lincoln Electric
LECO
$14.6B
| $2.81M | 0.01% |
22,365
-6,130
| -22% | -$827K |
|
674
Cable One
CABO
$249M
| $2.81M | 0.01% |
3,291
-90
| -3% | -$111K |
|
675
ResMed
RMD
$30.3B
| $2.79M | 0.01% |
12,769
-600
| -4% | -$137K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.